147 related articles for article (PubMed ID: 12383635)
21. Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves.
Ellis J; West K; Cortese V; Konoby C; Weigel D
J Am Vet Med Assoc; 2001 Aug; 219(3):351-6. PubMed ID: 11497051
[TBL] [Abstract][Full Text] [Related]
22. Vaccination of cattle against bovine viral diarrhoea.
van Oirschot JT; Bruschke CJ; van Rijn PA
Vet Microbiol; 1999 Jan; 64(2-3):169-83. PubMed ID: 10028171
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of long-term antibody responses to two inactivated bovine viral diarrhoea virus (BVDV) vaccines.
González AM; Arnaiz I; Yus E; Eiras C; Sanjuán M; Diéguez FJ
Vet J; 2014 Mar; 199(3):424-8. PubMed ID: 24461201
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of natural exposure to bovine viral diarrhea in a vaccinated herd by measuring extended antibody titers against bovine viral diarrhea virus.
Ross J
Can Vet J; 2003 Jan; 44(1):59-61. PubMed ID: 12619558
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
Fairbanks K; Schnackel J; Chase CC
Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
[TBL] [Abstract][Full Text] [Related]
26. Development of a fetal challenge method for the evaluation of bovine viral diarrhea virus vaccines.
Brock KV; Chase CC
Vet Microbiol; 2000 Nov; 77(1-2):209-14. PubMed ID: 11042414
[TBL] [Abstract][Full Text] [Related]
27. Prevention of fetal infection in heifers challenged with bovine viral diarrhoea virus type 1a by vaccination with a type 1c or type 1a vaccine.
Packianathan R; Clough WJ; Hodge A; Holz DK; Huang J; Bryant GL; Colantoni C
N Z Vet J; 2017 May; 65(3):134-139. PubMed ID: 28359226
[TBL] [Abstract][Full Text] [Related]
28. Lack of Fetal Protection against Bovine Viral Diarrhea Virus in a Vaccinated Heifer.
Klimowicz-Bodys MD; Polak MP; Płoneczka-Janeczko K; Bagnicka E; Zbroja D; Rypuła K
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215904
[TBL] [Abstract][Full Text] [Related]
29. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
30. BVDV vaccination in North America: risks versus benefits.
Griebel PJ
Anim Health Res Rev; 2015 Jun; 16(1):27-32. PubMed ID: 26050569
[TBL] [Abstract][Full Text] [Related]
31. Challenge with Bovine viral diarrhea virus by exposure to persistently infected calves: protection by vaccination and negative results of antigen testing in nonvaccinated acutely infected calves.
Fulton RW; Johnson BJ; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Burge LJ; Step DL; Walker DA; Payton ME
Can J Vet Res; 2006 Apr; 70(2):121-7. PubMed ID: 16639944
[TBL] [Abstract][Full Text] [Related]
32. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
Wang W; Shi X; Wu Y; Li X; Ji Y; Meng Q; Zhang S; Wu H
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):288-92. PubMed ID: 24880701
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
[TBL] [Abstract][Full Text] [Related]
35. Impact of species and subgenotypes of bovine viral diarrhea virus on control by vaccination.
Fulton RW
Anim Health Res Rev; 2015 Jun; 16(1):40-54. PubMed ID: 26050571
[TBL] [Abstract][Full Text] [Related]
36. Impact of three inactivated bovine viral diarrhoea virus vaccines on bulk milk p80 (NS3) ELISA test results in dairy herds.
Sayers RG; Sayers GP; Graham DA; Arkins S
Vet J; 2015 Jul; 205(1):56-61. PubMed ID: 25986132
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of three experimental bovine viral diarrhea virus killed vaccines adjuvanted with combinations of Quil A cholesterol and dimethyldioctadecylammonium (DDA) bromide.
Ridpath JF; Dominowski P; Mannan R; Yancey R; Jackson JA; Taylor L; Mediratta S; Eversole R; Mackenzie CD; Neill JD
Vet Res Commun; 2010 Dec; 34(8):691-702. PubMed ID: 20872289
[TBL] [Abstract][Full Text] [Related]
39. Control of bovine viral diarrhea infection by use of vaccination.
Bolin SR
Vet Clin North Am Food Anim Pract; 1995 Nov; 11(3):615-25. PubMed ID: 8581866
[TBL] [Abstract][Full Text] [Related]
40. Antibody responses to inactivated vaccines and natural infection in cattle using bovine viral diarrhoea virus ELISA kits: assessment of potential to differentiate infected and vaccinated animals.
Raue R; Harmeyer SS; Nanjiani IA
Vet J; 2011 Mar; 187(3):330-4. PubMed ID: 20074985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
